Anatomy of the antibody molecule

Molecular Immunology

Volumn 31, Issue 3, 1994, Pages 169-217

  Padlan, Eduardo A ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

antibody ligand interactions; humanization strategies; polyreactivity; X ray structures

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN G1;

AMINO ACID SEQUENCE; ANTIBODY COMBINING SITE; ANTIGEN ANTIBODY REACTION; HUMAN; IMMUNOGLOBULIN STRUCTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; X RAY ANALYSIS;

AMINO ACID SEQUENCE; ANIMAL; ANTIBODIES; CRYSTALLOGRAPHY, X-RAY; HUMAN; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA;

EID: 0028289241     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/0161-5890(94)90001-9     Document Type: Review

References (178)

1. Protein Data Bank
2. A strong propensity toward loop formation characterizes the expressed reading frames of the D segments at the Ig H and T cell receptor loci
3. A conformation of cyclosporin A in aqueous environment revealed by the X-ray structure of a cyclosporin-Fab complex
4. Three-dimensional structure of antibodies
5. Three-dimensional structure determination of an anti-2-phenyloxazolone antibody: the role of somatic mutation and heavy/light chain pairing in the maturation of an immune system
6. Three-dimensional structure of an antigenantibody complex at 2.8 Å resolution
7. Three-dimensional structure of immunoglobulins
8. The three dimensional structure of a combining region-ligand complex of immunoglobulin NEW at 3.5-A resolution
9. Use of deuterium labelling in NMR studies of antibody: combining site structure
10. Structure of HIV-1 reverse transcriptase-DNA complex at 7 Å resolution showing active site locations
11. Two murine natural polyreactive autoantibodies are encoded by nonmutated germ-line genes
12. Structure and function of the constant regions of immunoglobulins
13. The antigenic structure of proteins: a reappraisal
14. Catalytic antibodies
15. Three-dimensional structure of an idiotope-anti-idiotope complex
16. The Protein Data Bank. A computer-based archival file for macromolecular structures
17. Small rearrangements in structures of Fv and Fab fragments of antibody D1.3 on antigen binding
18. Single-chain antigen-binding proteins
19. Use of molecular replacement in the solution of an immunoglobulin Fab fragment structure
20. Crystal structure of a chimeric Fab' fragment of an antibody binding tumour cells
21. Solution of a Fab (26-10)/digoxin complex by generalized molecular replacement
22. 2.9 Å resolution structure of an anti-dinitrophenyl-spin-label monoclonal antibody Fab fragment with bound hapten
23. Molecular-replacement structure of guinea pig IgG1 pFc' refined at 31 Å resolution
24. Monoreactive high affinity and polyreative low affinity rheumatoid factors are produced by CD5+ B cells from patients with rheumatoid arthritis
25. Immunoglobulin G: functional sites
26. The conformation of antibodies
27. Antibody: the flexible adaptor molecule
28. HER2 antibody for human cancer therapy
29. Novel arrangement of immunoglobulin variable domains: X-ray crystallographic analysis of the γ-chain dimer Bence-Jones protein Loc
30. A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin
31. Canonical structures for the hypervariable regions of immunoglobulins
32. H segments
33. Conformation of immunoglobulin hypervariable regions
34. Domain association in immunoglobulin molecules The packing of variable domains
35. Humanized antibodies for therapy
36. Radioimmunolocalization of human carcinoma xenografts with B72.3 second generation (CC) monoclonal antibodies
37. Structure of antibody-antigen complexes: implications for immune recognition
38. Three-dimensional structure of a complex of antibody with influenza virus neuraminidase
39. Crystal and molecular structure of the dimer of variable domains of the Bence-Jones protein ROY
40. Three-dimensional structures of influenza virus neuraminidase-antibody complexes
41. Analytical molecular surface calculation
42. Crystallization and structure determination of an autoimmune anti-poly(dT) immunoglobulin Fab fragment at 3.0 A resolution
43. Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment
44. Antibody structure
45. Structural basis of antibody function
46. Twisting into shape
47. Three-dimensional structure of immunoglobulins
48. Immunoglobulin structures at high resolution
49. Antibodyantigen complexes
50. Antibody/antigen complexes
51. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of Protein A from Staphylococcus aureus at 2.9-and 2.8-Å resolution
52. Modeling of the combining sites of three anti-lysozyme monoclonal antibodies and of the complex between one of the antibodies and its epitope
53. Crystal structure of a streptococcal protein G domain bound to an Fab fragment
54. The binding site for C1q on IgG
55. Localization of the binding site for the human high-affinity Fc receptor for IgG
56. The covalent structure of an entire γG immunoglobulin molecule
57. Conformational flexibility in immunoglobulins
58. Binding of 2,4-dinitrophenyl compounds and other small molecules to a crystalline λ-type Bence-Jones dimer
59. The binding of opioid peptides to the Mcg light chain dimer: flexible keys and adjustable locks
60. HER2 antibody 4D5 and comparison with molecular modeling
61. Three-dimensional structure of a light chain dimer crystallized in water. Conformational flexibility of a molecule in two crystal forms
62. Unexpected similarities in the crystal structures of the Mcg light chain dimer and its hybrid with the Weir protein
63. Crystal and molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI
64. The molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI refined at 2.0 Å resolution
65. Three-dimensional structure of an Fv from a human IgM immunoglobulin
66. The structure determination of the variable portion of the Bence-Jones protein Au
67. Hydrogen bonding and biological specificity analysed by protein engineering
68. Crystallographic refinement of the three-dimensional structure of the FabD1.3-lysozyme complex at 2.5-Å resolution
69. Antibody framework residues affecting the conformation of the hypervariable loops
70. Structure of a novel Bence-Jones protein (Rhe) fragment at 1.6 Å resolution
71. Three-dimensional structure of an angiotensin II-Fab complex at 3 Å: hormone recognition by an anti-idiotypic antibody
72. The disulfide bonds in antibody variable domains: effects on stability, folding in vitro and function expression in Escherichia coli
73. 10) (GAT)-induced IgG monoclonal antibodies cross-react with various self and non-self antigens through the complementary determining regions. Comparison with IgM monoclonal polyreactive natural antibodies
74. The three-dimensional structure of an intact monoclonal antibody for canine lymphoma
75. Structure of a human monoclonal antibody Fab fragment against gp41 of human immunodeficiency virus type 1
76. The interaction of human IgE with class-specific Fc-receptors
77. The nature and biological importance of the inter-s chain disulfide bonds in human IgE
78. An autoantibody to single-stranded DNA: comparison of the three-dimensional structures of the unliganded Fab and a deoxynucleotide-Fab complex
79. Three-dimensional structure of a fluorescein-Fab complex crystallized in 2-methyl-2,4-pentanediol
80. Structural basis for antigen-antibody recognition
81. Antibody-antigen flexibility
82. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli
83. The structure of protein-protein recognition sites
84. High resolution functional analysis of antibody-antigen interactions
85. Replacing the complementarity-determining regions in a human antibody with those from a mouse
86. Unusual distribution of amino acids in complementarity-determining (hypervariable) segments of heavy and light chains of immunoglobulins and their possible roles in specificity of antibody combining sites
87. Variable region genes for the immunoglobulin framework are assembled from small segments of DNA—a hypothesis
88. Sequences of Proteins of Immunological Interest
89. Dictionary of protein secondary structure: pattern recognition of hydrogenbonded and geometrical features
90. h clan and family identity predicts variable domain structure and may influence antigen binding
91. Continuous cultures of fused cells secreting antibodies of predefined specificity
92. Three-dimensional structure of two crystal forms of FabR19.9 from a monoclonal anti-arsonate antibody
93. Catalytic antibodies
94. Crystallization, preliminary X-ray diffration study, and crystal packing of a complex between anti-hen lysozyme antibody F9.14.7 and guinea-fowl lysozyme
95. Elbow motion in the immunoglobulins involves a molecular ball-and-socket joint
96. Aromatic rings act as hydrogen bond acceptors
97. Probing antibody diversity by 2D NMR: comparison of amino acid sequences, predicted structures, and observed antibody-antigen interactions in complexes of two antipeptide antibodies
98. Properties of polyreactive natural antibodies to self and foreign antigens
99. Resolution d'une structure cristalline lorsque les positions d'une partie des atomes sont connues traitment statistique
100. The structural basis of antigen-antibody recognition
101. Crystallographic refinement and atomic models of the intact immunoglobulin molecule Kol and its antigen-binding fragment at 3.0 A and 1.9 A resolution
102. Structure, function and properties of antibody binding sites
103. Protein-protein recognition and the association of immunoglobulin constant domains
104. Chimeric human antibody molecules: mouse antigenbinding domains with human constant region domains
105. Genetically-engineered antibody molecules
106. Molecular anatomy of the antibody binding site
107. On the attribution of binding energy in antigen-antibody complexes McPC603, D1.3 and HyHEL-5
108. L domain dimers
109. Electrostatic fields in antibodies and antibody/antigen complexes
110. Structural basis for the specificity of antibody-antigen reactions and structural mechanisms for the diversification of antigen-binding specificities
111. Structural implications of sequence variability in immunoglobulins
112. On the nature of antibody combining sites: unusual features that may confer on these sites an enhanced capacity for binding ligands
113. X-ray diffraction studies of antibody constant regions
114. A possible procedure for reducing the immunogenicity of antibody variable domains while preserving their ligand-binding properties
115. Structure of protein epitopes deduced from X-ray crystallography
116. On the specificity of antibody/antigen interactions: phosphocholine binding to McPC603 and the correlation of three-dimensional structure and sequence data
117. Antibody Fab assembly: the interface residues between CH1 and CL
118. Variability of three-dimensional structure in immunoglobulins
119. A model of the Fc of immunoglobulin E
120. Structural basis for the specificity of phosphorylcholinebinding immunoglobulins
121. Structure at 4.5 Å resolution of a phosphorylcholine-binding Fab
122. Structure of an antibody-antigen complex: crystal structure of the HyHEL-10 Fab-lysozyme complex
123. Solution structure of human and mouse immunoglobulin M by synchrotron X-ray scattering and molecular graphics modeling. A possible mechanism for complement activation
124. Structural basis for the association of heavy and light chains and the relation of subgroups to the conformation of the active site of immunoglobulins
125. Structure and specificity of antibody molecules
126. Studies on the three-dimensional structure of immunoglobulins
127. Three-dimensional structure of the Fab' fragment of a human immunoglobulin at 28-Å resolution
128. The three-dimensional structure of the Fab' fragment of a human myeloma immunoglobulin at 2.0-Å resolution
129. Localized insertion-deletion mutations: a major factor in the evolution of immunoglobulin structural variability
130. Structure determination of a monoclonal Fab fragment specific for histidine-containing protein of the phosphoenolpyruvate:sugar phosphotransferase system of Escherichia coli
131. Computer models of the human immunoglobulins: shape and segmental flexibility
132. A humanized antibody that binds to the interleukin 2 receptor
133. Three-dimensional structure of the Mcg IgGl immunoglobulin
134. Reshaping human antibodies for therapy
135. Structural evidence for induced fit as a mechanism for antibody-antigen recognition
136. The three-dimensional structure of a human IgGl immunoglobulin at 4 Å resolution a computer fit of various structural domains on the electron density map
137. The three-dimensional structure at 6 Å resolution of a human γG1 immunoglobulin molecule
138. Stereochemical criteria for polypeptide and protein structures
139. Phosphocholine binding immunoglobulin Fab McPC603. An X-ray diffraction study at 2.7 Å
140. Crystal structure of human immunoglobulin fragment Fab New refined at 2.0 Å resolution
141. Structure of a second crystal form of Bence-Jones protein Loc: strikingly different domain associations in two crystal forms of a single protein
142. Analysis of immunoglobulin domain interactions. Evidence for a dominant role of salt bridges
143. Structure of a λ-type Bence-Jones protein at 35-Å resolution
144. Antibodies in cancer therapy: basic principles and applications
145. New concepts in monoclonal antibody based radioimmunodiagnosis and radioimmunotherapy of carcinoma
146. The interplay between chemistry and biology in the design of enzymatic catalysts
147. The three-dimensional structure of a phosphorylcholine-binding mouse immunoglobulin Fab and the nature of the antigen binding site
148. Three-dimensional structure of an antibody-antigen complex
149. Crystal parameters and molecular replacement of an anticholera toxin peptide complex
150. Three-dimensional structure of an intact human immunoglobulin
151. Crystal structures of an antibody to a peptide and its complex with peptide antigen at 2.8 Å
152. Immunoglobulin disulfide bridges: theme and variations
153. The use of monoclonal antibodies for treatment of autoimmune disease
154. Refined crystal structure of a recombinant immunoglobulin domain and a complementarity-determining region 1-grafted mutant
155. L related fragment of the human κI Bence Jones protein Wat
156. Three-dimensional structure of murine anti-p-azophenylarsonate Fab 36–71. I. X-ray crystallography, site-directed mutagenesis, and modeling of the complex with hapten
157. The galactan-binding immunoglobulin Fab J539: an X-ray diffraction study at 2.6 A resolution
158. The three-dimensional structure of the carbohydrate within the Fc fragment of immunoglobulin G
159. Influence of the hinge region on the complement activation, Clq binding and segmental flexibility in chimeric human immunoglobulins
160. Reshaping a human monoclonal antibody to inhibit human respiratory syncytial virus infection in vivo
161. Structural and kinetic studies of the Fab fragment of a monoclonal anti-spin label antibody by nuclear magnetic resonance
162. Three-dimensional structure of the Fab fragment of a neutralizing antibody to human rhinovirus serotype 2
163. H domains of immunoglobulins
164. Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex
165. Crystal structures of neuraminidase-antibody complexes
166. Crystal structures of two mutant neuraminidase-antibody complexes with amino acid substitutions in the interface
167. Reshaping human antibodies: grafting an antilysozyme activity
168. Crystal structure of an anti-Lewis a Fab determined by molecular replacement methods
169. Crystallographic analysis of the interaction between cyclosporin A and the Fab fragment of a monoclonal antibody
170. Monoclonal antibodies in diagnosis and therapy
171. Structural aspects of antibodies and antibody-antigen complexes
172. Antibody engineering
173. An analysis of the sequences of the variable regions of Bence-Jones proteins and myeloma light chains and their implication for antibody complementarity
174. Length distribution of CDRH3 in antibodies
175. Conformation of IgE bound to receptor and in solution
176. Dynamic conformations compared for IgE and IgG1 in solution and bound to receptors